Georgia Tomaras Receives 2025 Faculty Award
DHVI member Georgia Tomaras, PhD, the A. Geller Distinguished Professor for Research in Immunology received a Research Mentoring Award, which recognizes excellence in mentoring across clinical, translational, population health, and basic sciences. She was honored for career mentoring in basic science.
Duke Named a Global Virus Network Center of Excellence
Duke University School of Medicine has joined the Global Virus Network (GVN) as one of its newest Centers of Excellence. Collaborating entities include the Duke Research and Discovery @RTP, the Duke Global Health Institute and the Duke Human Vaccine Institute (DHVI).
Duke Team Identifies a Strategy to Guide the Immune System to Respond to HIV
Highly specific HIV antibodies could be induced by vaccination using a new strategy developed by researchers at the Duke Human Vaccine Institute
Experimental Flu Vaccines to be Made at Duke
The Duke Human Vaccine Institute has been awarded a $7 million contract from the National Institute of Allergy and Infectious Diseases (NIAID), to manufacture H5N1 avian flu vaccines for use in cli
Omicron XBB Insights Could Shape Future COVID-19 Vaccine Design
A Duke University School of Medicine study in Molecular Cell provides the most detailed look yet at the SARS-CoV-2
DHVI Receives Contract to Manufacture Investigational Avian Flu Vaccines
The Duke Human Vaccine Institute received funding from the National Institute of Allergy and Infectious Diseases (NIAID), a branch of the National Institutes of Health, to manufacture H5N1 avian fl
2024 William G. Anlyan Lifetime Achievement Award Barton F. Haynes, MD, HS’73-’75
Barton F. Haynes, MD, HS’73 -’75, is the Frederic M.
A Trial HIV Vaccine Triggered Elusive and Essential Antibodies in Humans
An HIV vaccine candidate developed at the Duke Human Vaccine Institute triggered low levels of an elusive type of broadly neutralizing HIV antibodies